SBC Medical Group Holdings Incorporated

SBCNASDAQIndustrials● Active

$2.96

$-0.05(-1.66%)

Market Cap$304426972

P/E Ratio—

52W High$5.75

52W Low$2.78

Avg Volume113K

Open$3.00

Beta0.59

Forecast Market Cap PE Ratio

SBC Medical Group Holdings Incorporated (SBC) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

sbc · stock forecast · 1 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 1 Wall Street analysts in the past 3 months

Buy

1 analysts

consensus

Rating Breakdown

Strong Buy

Buy

Hold

Sell

Strong Sell

Total: 1 · Buy rate: 100.0%

12-Month Price Target

High

$15.00

Consensus

$12.00

+301.3% upside

Low

$9.00

Median: $12 · Last Close: $2.99

The SBC Medical Group Holdings Incorporated (SBC) analyst consensus is Buy, based on ratings from 1 Wall Street analysts over the past 3 months. The average 12-month SBC price target is $12.00, representing +301.3% upside from the current price of $2.99.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $12 (301.3%)High $15Low $9

Consensus Target

$12.00

301.3% upside

High Target

$15

401.7%

Low Target

201.0%

Current Price

$2.99

as of today

Based on analyst price targets, the SBC stock price prediction for the next 12 months ranges from $9 to $15. The consensus SBC price forecast of $12.00 implies 301.3% upside from the current price of $2.99.

Short-Term Price Prediction

Bear

Algorithmically generated · Updated daily

Date	Predicted Price	Change	Min	Max
2026-06-09	$2.96	↓ 1.05%	$2.94	$2.98

1-day model range: $2.94–$2.98. Peak: $2.98 (-1.05%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

Year	Low	Avg Price	High	Change
2027	$2	$2	$2	-39.2%
2028	$1	$1	$1	-52.3%
2029	$1	$1	$1	-58.0%
2030	$1	$1	$1	-60.7%
2031	$1	—	$1	-62.1%

Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%

0Buy

1Neutral

13Sell

RSI (14)56.5Neutral

MACDBEARISH

Refreshes daily from EOD close

Moving Averages · SBC · Jun 8, 2026

Simple Moving Average (SMA)

MA 5$3.07SELL

MA 10$3.12SELL

MA 20$3.10SELL

MA 50$3.54SELL

MA 100$3.84SELL

MA 200$3.92SELL

Current $SBC · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$3.05SELL

EMA 10$3.08SELL

EMA 20$3.15SELL

EMA 50$3.40SELL

EMA 100$3.65SELL

EMA 200$4.00SELL

Current $SBC · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:

Date	Brokerage	Action	Rating

Wall Street analysts have recently issued updated ratings on SBC Medical Group Holdings Incorporated (SBC) stock. Of the recent 0 rating actions, 0 were upgrades and 0 were downgrades. 1 analysts currently cover SBC.

Analyst Recommendation Trends

SBC analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$218M

↑ 20.3% YoY

Revenue Next Year

$179M

↓ 17.6% YoY

EPS This Year

$0.59

EPS Next Year

$0.46

↓ 22.6% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast SBC EPS of $0.59 for the current fiscal year, based on estimates from 2 analysts. The SBC revenue forecast is $218M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The SBC stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SBC price target is $12.00 (+301.3% upside), with an analyst consensus of Buy.

The SBC short-term stock prediction for tomorrow is $2.96 (-1.05%). The SBC stock price prediction for 2027 estimates an average of $2. The SBC stock prediction for 2030 projects a range of $1–$1.

SBC Medical Group Holdings Incorporated trades on NASDAQ under the ticker SBC. The SBC stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Earnings Revenue PE Ratio Financials Market Cap Insider Trades Dividends Price History

Frequently asked questions

SBC forecast · 8 questions

According to 1 Wall Street analysts, the average 12-month SBC price target is $12.00, with a high forecast of $15.00 and a low of $9.00. The median price target is shown in the chart above when available. This implies +301.3% potential upside from the current price of $2.99.

SBC price targetWhat is SBC price targetSBC analyst price targetSBC 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.